Mayo Clinic Launches National Mobile Exhibit Tour to Honor 150 Years, Look to the Future

Posted on April 22nd, 2014 by Center for Individualized Medicine


To honor 150 years of serving humanity, Mayo Clinic is taking its story to the public in a free exhibit destined for stops in more than 40 communities throughout the U.S. and Canada from April through October 2014. This high-impact, 1,000-square-foot exhibition on wheels will bring to life Mayo Clinic’s values and our vision for the future of health care.

Mayo Clinic Sesquicentennial Mobile Exhibit

“Throughout our history, people have turned to Mayo Clinic for hope and healing. By experiencing this exhibit you will share the enduring values and exciting vision of Mayo Clinic in service to humanity,” says Kerry Olsen, M.D., Chair, Mayo Clinic Sesquicentennial Committee.

What’s inside?
A [...]

View more...

#DNADay Twitter Chat

Posted on April 21st, 2014 by Center for Individualized Medicine


This Friday, April 25th, we are celebrating DNA Day, and to kick off the festivities, we are hosting our first Twitter Chat from the Center for Individualized Medicine. Join us as at 12:00pm (Central Standard Time) as we discuss the work that has come about since the Human Genome Project, and how Health Care has changed because of it. We'll also talk about the challenges faced by those working in Individualized Medicine, and where research is taking us for making medicine more personalized.

If this is your first Twitter Chat, we recommend using TweetChat to participate and follow along with the conversation. Below you'll find our questions for the [...]

View more...

Sanguine to begin work with Mayo Clinic Bioservices

Posted on April 16th, 2014 by Center for Individualized Medicine

Article Originally Featured on PR Newswire

Sanguine, a technology company enabling personalized medical research for the development of new and effective treatments, today announced an agreement with Mayo Clinic Bioservices. Under this agreement, Mayo Clinic Bioservices will process, store and ship biospecimens that Sanguine has collected for clients developing new therapies. This will dramatically increase Sanguine's capacity and scalability, allowing the company to serve more clients simultaneously.

Mayo Clinic Bioservices will provide integrated laboratory services that are vital to basic, translational and epidemiological research, including specimen accessioning, processing, nucleic acid extraction, specimen tracking, storage and shipping. Mayo Clinic Bioservices is a new service from the Mayo Clinic Center for Individualized Medicine with locations [...]

View more...

Lessons Learned from Genomics Clinic for Sequencing-based Cancer Care and Diagnostics

Posted on April 10th, 2014 by Center for Individualized Medicine


Article Originally Featured on Mayo Clinic News Network


It has been 1.5 years since Mayo Clinic opened the world’s first integrated multidisciplinary genomics service, the Individualized Medicine Clinic, which uses genomics and next-generation sequencing technologies to personalize treatments for patients with advanced cancer and complex diagnoses. In a special issue of the American Journal of Medical Genetics Part C“Implementation of Genomic Medicine,” developers of the Individualized Medicine Clinic report the clinic’s structure and share lessons learned in everything from efficacy of genomics in patient [...]

View more...

Children Benefit from Fecal Transplant to Combat C. Difficile

Posted on April 8th, 2014 by Center for Individualized Medicine


Article Originally Featured in Digestive Disease Update

To address the issues of rising cases in children with cases of Clostridium difficile (C. difficile), and the rise of recurrence in children, Mark G. Bartlett, M.D., a pediatric gastroenterologist at Mayo Clinic in Rochester, Minn. initiated a fecal microbiota transplant program for young patients with refractory C. difficile infection in April 2013. Fecal transplants, which aim to restore a normal gut microbiome, have an overall cure rate of more than 90 percent. "At that time, just a few places were doing fecal transplants in children, but we felt we were ready. Mayo Clinic in Arizona has had an [...]

View more...

Implementing Individualized Medicine into the Medical Practice

Posted on April 4th, 2014 by AJ Montpetit

From Promise to Practice


There is increasing recognition that genomic medicine as part of individualized medicine has a defined role in patient care. Rapid advances in technology and decreasing cost combine to bring genomic medicine closer to the clinical practice. There is also growing evidence that genomic-based medicine can advance patient outcomes, tailor therapy and decrease side effects.


The promise of genomic medicine, as one part of individualized care, is to enable medical practitioners to make better clinical decisions through an improved informed process.


However the challenges to integrate genomics into the workflow involved in patient care remain vast, stalling assimilation [...]

View more...

ACMG Updates Recommendation on “Opt Out” for Genome Sequencing Return of Results

Posted on April 1st, 2014 by Center for Individualized Medicine


Today's Press Release From ACMG


BETHESDA, Md., APRIL 1, 2014 -- /PRNewswire-USNewswire/ -- There has been significant discussion surrounding the initial ACMG recommendations for the return of results from genome-scale sequencing issued in March of 2013. The ACMG Board of Directors has listened carefully to the members' views and appreciates the many forums in which divergent and valuable opinions have been expressed. The positions of ACMG members regarding the issues raised by the recommendations have been assessed through a variety of mechanisms, including direct feedback, participation by Board members in numerous forums exploring these issues, informal conversations, published articles, commentaries and, most recently, through an extensive member survey, the results of which were presented at the ACMG business meeting at [...]

View more...

ACMG Annual Clinical Genetics Meeting 2014 Schedule

Posted on March 27th, 2014 by Admin

ACMG Annual Clinical Genetics Meeting

This year at the ACMG Annual Clinical Genetics Meeting, Richard Sharp, Ph.D., director of the Bioethics Program in the Mayo Clinic Center for Individualized Medicine, will participate on Saturday, March 30, in a panel discussion entitled “Duty to Recontact” in the Genomics Era: Interdisciplinary Perspectives and Open Forum.

“Duty to Recontact” addresses providers’ obligations to patients who have undergone previous genetic testing, given the growing complexities of genetic/genomic medicine and the potential for new findings in old tests. Dr. Sharp is an advisor to the National Institutes of Health, the Institute of Medicine and the Environmental Protection [...]

View more...

Load More